Results 61 to 70 of about 12,482 (250)

Quality of life in allergic rhinitis - children’s and their parents’ perspective in polish urban and rural population

Health and Quality of Life Outcomes, 2020
Background Allergic rhinitis is a common chronic condition in the paediatric population. No reports regarding the quality of life in children with allergic rhinitis in the Polish population have been found in the available literature.
Hanna Sikorska-Szaflik, Barbara Sozańska   +1 more
doaj   +1 more source

Emollient Formulations and Skin Barrier Practices in the Context of Eczema and Food Allergy Prevention

Allergy, EarlyView.
ABSTRACT The skin is far from a passive shield; it functions as a dynamic “living barrier” whose structural and immunological integrity is paramount in preventing atopic dermatitis (AD) and the subsequent progression of the atopic march toward food allergy (FA).
Klaudia Ryczaj, Donald Y. M. Leung, Carina Venter, Barbara Sozańska, Helen A. Brough   +4 more
wiley   +1 more source

Seasonal variation in Allergic Rhinitis/Conjunctivitis/Rhinoconjunctivitis current symptoms

, 2015
Seasonal variation in Allergic Rhinitis/Conjunctivitis/Rhinoconjunctivitis current ...
David P. Strachan (110302), Michael R. Perkin (624621), Christopher G. Owen (168863), Alicja R. Rudnicka (168859), Tara Bader (830312)   +4 more
core   +1 more source

Postcode‐Level Variation and Environmental Determinants of Respiratory Allergies in a Large German Cohort

Allergy, EarlyView.
Young children (0–9 years) and residents of urban areas appeared particularly vulnerable to respiratory allergy development and exacerbation. Incidence showed nonlinear associations with PM10, PM2.5, temperature, and alder/birch pollen, while DPMR showed similar patterns, except for NO2 and the interaction O3*NO2.
Trang Dao‐Siebel, Christoph Knote, Christoph Müller, Thilo Erbertseder, Elke Hertig, Roxana Halbleib, Evelyn Lamy   +6 more
wiley   +1 more source

Relationship Between Rhinitis, Asthma, and Eczema and the Presence of Sensitization in Young Swiss Adults

Allergy & Rhinology, 2018
Background Rhinitis is a very common disease with allergies being the most frequent causative factor. It can co-occur together with asthma and eczema in atopic as well as in nonatopic patients.
Urs C. Steiner MD, Lucas M. Bachmann MD, PhD, Micheal B. Soyka MD, Stephan Regenass MD, Lukas Steinegger MD, Elsbeth Probst MD   +5 more
doaj   +1 more source

Questionnaire Survey on Loquat‐Induced Oral Allergy Syndrome in School Children in Yamanashi, Japan

Allergy, EarlyView.
Ayumi Shimamura, Reiji Kojima, Hiroki Ishii, Tomokazu Matsuoka, Hisatake Ikeda, Daiju Sakurai   +5 more
wiley   +1 more source

Efficacy and Safety of Dupilumab in Chinese Adult Patients With Chronic Rhinosinusitis With Nasal Polyps: A Randomized, Placebo‐Controlled, Phase III Trial

Allergy, EarlyView.
Dupilumab significantly improved nasal polyp score, nasal congestion, olfaction, total symptom score, and disease‐specific quality of life in Chinese patients with uncontrolled CRSwNP. Incidence of treatment‐emergent adverse events was similar between dupilumab and placebo.
Mu Xian, Menglin Wang, Changqing Zhao, Lijia Wan, Yu Xu, Juan Meng, Rui Xu, Xicheng Song, Li Shi, Yucheng Yang, Yan Jiang, Yanzhen Wu, Bethany Ling, Vivian Li, Andrew P. Fontenot, Lacey R. Robinson, Neelam A. Phadke, Chengshuo Wang, Luo Zhang   +18 more
wiley   +1 more source

Does treatment of gastro-esophageal reflux disease with omeprazole decrease allergic rhinitis symptoms?

Iranian South Medical Journal, 2014
Background: Allergic rhinitis is the most common type of allergic disease among population. Its accurate treatment is very important for cutting of allergic march.
Afshin Shirkani, Farahzad Jabbariazad, Reza Faridhosseini   +2 more
doaj  

Remission in Global Airway Diseases: EUFOREA Consensus Paper

Allergy, EarlyView.
ABSTRACT The therapeutic goal in chronic airway diseases is shifting from symptom control to disease remission. Disease‐modifying therapies, including biologics and allergen immunotherapy, have made remission achievable in patients with severe asthma, chronic rhinosinusitis with nasal polyps (CRSwNP), or allergic rhinitis (AR).
J. Christian Virchow, Xander Bertels, Vibeke Backer, Benjamin S. Bleier, Marco Caminati, Diego M. Conti, Eugenio De Corso, Mina Gaga, Valerie J. Lund, Corrado Pelaia, Anju T. Peters, Glenis K. Scadding, Martin Wagenmann, Riyad O. Al‐Lehebi, Guy G. Brusselle, Philippe Gevaert, Liam G. Heaney, Stella E. Lee, Florence Schleich, Frederik Trinkmann, Peter W. Hellings, Wytske J. Fokkens, Paola Rogliani   +22 more
wiley   +1 more source

Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines-2024-2025 Revision: Part II-Guidelines on Oral and Ocular Treatments. [PDF]

Allergy
ABSTRACT Background Oral and ocular medications are frequently used in the treatment of allergic rhinitis (AR). As part of the update of the Allergic Rhinitis and its Impact on Asthma (ARIA)‐EAACI guidelines, this manuscript presents the ARIA‐EAACI 2024–2025 recommendations for oral and ocular treatments.
Vieira RJ, Sousa-Pinto B, Bousquet J, Schünemann HJ, Zuberbier T, Bognanni A, Togias A, Samolinski B, Valiulis A, Williams S, Bedbrook A, Czarlewski W, Torres MJ, Shamji MH, Morais-Almeida M, Canonica GW, Vecillas LL, Dykewicz MS, Jacomelli C, Klimek L, Leemann L, Lourenço O, Papadopoulos NG, Pereira AM, Savouré M, Toppila-Salmi SK, Ventura MT, Yepes-Nuñez JJ, Cruz AA, Ciprandi G, Gemicioglu B, Giovannini M, Gradauskiene B, Jartti T, Jeseňák M, Kuna P, Kvedariene V, Larenas-Linnemann DE, Latiff AHA, Mohammad Y, Ohta K, Mahesh PA, Pali-Schöll I, Pfaar O, Regateiro FS, Roche N, Taborda-Barata L, Ulrik CS, Viegi G, Zhang L, Haahtela T, Cherrez-Ojeda I, Ivancevich JC, Khaltaev N, Yorgancioglu A, Abdullah B, Al-Ahmad M, Al-Nesf MA, Amaral R, Asllani J, Bergmann KC, Bernstein JA, Blaiss MS, Toskala E, Carreiro-Martins P, Casale T, Cecchi L, Fiocchi A, Giuliano AFM, Christoff G, Cirule I, de Sousa JC, Costa EM, Devillier P, Hossny E, Iinuma T, Ispayeva Z, Julge K, Kaidashev I, Bennoor KS, Kraxner H, Kull I, Kulus M, Kupczyk M, Kurchenko A, La Grutta S, Miculinic N, Tuyet LLT, Lee SM, Montefort S, Moreira A, Mullol J, Nadif R, Nakonechna A, Neffen HE, Niedoszytko M, O'Hehir RE, Ogulur I, Okamoto Y, Olze H, Palomares O, Panzner P, Patella V, Pitsios C, Puggioni F, Quirce S, Ramonaité A, Repka-Ramirez MS, Roberts G, Robles-Velasco K, Rottem M, Salapatas M, Sastre J, Scichilone N, Sisul JC, Solé D, Soto-Martinez ME, Sova M, Tantilipikorn P, Todo-Bom A, Tsaryk V, Tsiligianni I, Urrutia-Pereira M, Valovirta E, Vasankari T, Wallace D, Wang Y, Worm M, Yusuf OM, Gil-Mata S, Marques-Cruz M, Mahboub B, Romano A, Aberer W, Artesani MC, Azzolini E, Barreto B, Bartra J, Becker S, Beghe B, Boner A, Borowiack E, Bouchard J, Brussino L, Buhl R, Catamerò F, Charpin D, Chavannes NH, Chełmińska M, Cheng L, Chkhartishvili E, Cho SH, Chong-Neto HJ, Chu DK, Cingi C, Compalati E, Costa RA, Cvetkovski B, Cardona V, D'Amato G, Davies JM, Di Bona D, Gonzalez Diaz SN, Dimou MV, Doulaptsi M, Ferreira-da-Silva R, Gawlik R, Calvo-Gil M, Gómez MR, Gotua M, Grigoreas C, Guzman MA, House R, Hyland M, Ierodiakonou D, Karavelia A, Keith P, Kisiel M, Kosak TS, Kosnik M, Koyuncu IV, Kritikos V, Litynska J, Lombardi C, Louis G, Luo X, Martini M, Meço C, Mesonjesi E, Mihaltan F, Moniuszko M, Naclerio RN, Neisinger S, Ollert M, Ordak M, Paoletti G, Parmelli E, Perdomo-Flores EA, Pereira H, Pérez JMF, Pham-Thi N, Prokopakis E, Ribeiro-Vaz I, Rolla G, Romantowski J, Rombaux P, Rouadi PW, Ryan D, Sadowska E, Sakurai D, Salameh L, Serrano E, Da Silva J, Soyka MB, Specjalski K, Tomic-Spiric V, Stevanovic K, Subramaniam A, Thomander T, Tong W, Vachova M, van Hage M, Wagenmann M, Ko FWS, Werminghaus P, Xepapadaki PV, Xiang YK, Yang Q, Zhang H, Zuberbier J, Fonseca JA.   +230 more
europepmc   +2 more sources